Leslie Stolz
Conseiller Juridique Général chez VERVE THERAPEUTICS, INC.
Profil
Leslie Stolz is currently working as the Senior Vice President-Regulatory Affairs at Verve Therapeutics, Inc. Prior to this, Leslie worked as the Vice President-Regulatory Strategy at Syntimmune, Inc. Leslie holds a doctorate degree from Duke University and an undergraduate degree from Villanova University.
Postes actifs de Leslie Stolz
Sociétés | Poste | Début |
---|---|---|
VERVE THERAPEUTICS, INC. | Conseiller Juridique Général | 01/06/2019 |
Anciens postes connus de Leslie Stolz
Sociétés | Poste | Fin |
---|---|---|
Syntimmune, Inc.
Syntimmune, Inc. BiotechnologyHealth Technology Syntimmune, Inc. engages in the research and development of therapeutics for autoimmune diseases based on neonatal Fc receptor biology. Its pipeline include SYNT001 which has target indication for dermatology, hematology, and neurology. It also focuses on pre-clinical investigation of SYTN002 and related compounds such as peptide mimetics. The company was founded by Laurence J. Blumberg and Richard S. Blumberg in 2013 and is headquartered in Boston, MA. | Corporate Officer/Principal | 01/01/2018 |
Formation de Leslie Stolz
Duke University | Doctorate Degree |
Villanova University | Undergraduate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
Sociétés cotées | 1 |
---|---|
VERVE THERAPEUTICS, INC. | Health Technology |
Entreprise privées | 1 |
---|---|
Syntimmune, Inc.
Syntimmune, Inc. BiotechnologyHealth Technology Syntimmune, Inc. engages in the research and development of therapeutics for autoimmune diseases based on neonatal Fc receptor biology. Its pipeline include SYNT001 which has target indication for dermatology, hematology, and neurology. It also focuses on pre-clinical investigation of SYTN002 and related compounds such as peptide mimetics. The company was founded by Laurence J. Blumberg and Richard S. Blumberg in 2013 and is headquartered in Boston, MA. | Health Technology |